News

Antibiotic resistance threatens not only the treatment of common infections but also modern medical procedures such as cancer treatment and surgery. In an opinion article published in Norwegian on Forskersonen on October 14, 2026, Professor Nina Langeland and Professor Magne O. Sydnes from the University of Bergen discuss the growing threat of antibiotic resistance and Read More

Antimicrobial resistance (AMR) is reducing the effectiveness of life-saving treatments, posing a serious and growing threat to global health and undermining the foundations of modern medicine. The latest WHO report shows that resistance to essential antibiotics, particularly among Gram-negative bacteria, is widespread, increasing and unevenly distributed. As a result first-choice treatments for common infections of Read More

Researchers working across microbiology, medicine, environmental science, public health and social science gathered at Solstrand on 24–25 August for the annual CAMRIA meeting, presenting new findings and ongoing research on antimicrobial resistance (AMR). The two-day programme covered a wide range of topics, from the status update on the current AMR situation in Europe to environmental Read More

Marit Andrea Klokkhammer Hetland defended her PhD thesis at the University of Bergen on 19 May, 2026. Her research examined how Klebsiella pneumoniae, an important cause of infections and antimicrobial resistance worldwide, moves from harmless carriage in the gut to causing disease. Using DNA analyses of more than 3,000 bacterial isolates from humans, animals and Read More

Research from CAMRIA centre explores how individual voices can influence public understanding of antimicrobial resistance (AMR) and why effective communication from health authorities matters. Antimicrobial resistance is a major global health challenge, yet it often receives limited attention in public debate. Unlike sudden health emergencies such as the COVID-19 pandemic, AMR develops gradually, making it Read More

Every year, hundreds of thousands of children die from diarrhoeal diseases – even though vaccines exist. Now, CAMRIA researchers  are leading a large new EU-funded project that aims to make life-saving vaccines work better for children in low-income countries. The four-year project, called PRoRota, has received more than 5 million euros in funding and will Read More

This year at Arendalsuka — Norway’s largest gathering for politics, business, NGOs, academia, and the public — CAMRIA was in the spotlight. Nina Langeland and Magne Sydnes from the University of Bergen took the initiative to host the event Har Norge rett medisin for å takle legemiddelmangelen? (Does Norway have the right medicine to address Read More

A major new study co-authored by CAMRIA researchers—Sabrina John Moyo, Iren Høyland Löhr, Joel Manyahi, Eva Bernhoff, Bjørn Blomberg, and Nina Langeland—has just been published and is now available online. The trial, titled “Home administration of a multistrain probiotic once per day for 4 weeks to newborn infants in Tanzania (ProRIDE): a double-blind, placebo-controlled randomised Read More

We’re excited to announce that CAMRIA will once again gather for our annual meeting on May 12, 2025, at the beautiful Solstrand Hotel. This special event brings together our community of PhD students, postdocs and group leaders to share their latest research, recent publications and exciting developments since our last gathering. It’s a valuable opportunity Read More

On the occasion of last week’s Antimicrobial Resistance Awareness Week, CAMRIA researchers Nina Landeland and Magne Olav Sydnes published a news piece on forskersonen.no. The blog post, titled “Kjemikere jobber iherdig med å ta knekken på antibiotikaresistensen” (The Chemists are Working Hard to Defeat Antibiotic Resistance), offers valuable insights into antimicrobial resistance from the perspective Read More